The tumor cells themselves also do not express one of the two key receptors involved in the cellular internalization of rhASM – MRC1 – which also likely contributes to the diminished capacity of rhASM to reach HCC tumors in vivo. Here, MRC1 is linked to hepatocellular carcinoma.